Literature DB >> 15887856

Association between vitamin D receptor FokI. Polymorphism and serum parathyroid hormone level in patients with chronic renal failure.

E Vigo Gago1, C Cadarso-Suárez, R Perez-Fernandez, R Romero Burgos, J Devesa Mugica, C Segura Iglesias.   

Abstract

We investigated the relationship between vitamin D receptor (VDR) start codon polymorphism and serum levels of PTH, calcidiol, and calcium in 64 Spanish patients with chronic renal failure (CRF). An exon 2 fragment of the VDR gene was amplified by PCR, and cleaved with the restriction enzyme FokI. The alleles were identified according to the digestion pattern obtained as F (absence of restriction site) and f (presence of restriction site). Genotype frequencies in the patient population were 54.7% FF, 28.1% Ff and 17.2% ff, vs 46.7% FF, 43.3% Ff and 10% ff in a healthy control population. The difference between the two populations was statistically significant (p<0.01). Within the patient population, mean serum PTH level in the FF group was significantly higher (159.77+/-25.69 pg/ml) than in both the Ff and ff groups (106.67+/-19.07 and 77.55+/-15.85 pg/ml, respectively; p<0.05). However there were no significant differences in serum levels of calcidiol or calcium among genotypes. These results suggest that FokI polymorphisms of the VDR gene may determine parathyroid response in CRF patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887856     DOI: 10.1007/bf03345353

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Vitamin D receptor gene start codon polymorphism (FokI) and bone mineral density in healthy male subjects.

Authors:  R M Kanan; S S Varanasi; R M Francis; L Parker; H K Datta
Journal:  Clin Endocrinol (Oxf)       Date:  2000-07       Impact factor: 3.478

Review 2.  Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate.

Authors:  J Silver; C Yalcindag; A Sela-Brown; R Kilav; T Naveh-Many
Journal:  Kidney Int Suppl       Date:  1999-12       Impact factor: 10.545

3.  Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease.

Authors:  K Yokoyama; T Shigematsu; T Tsukada; Y Ogura; F Takemoto; S Hara; A Yamada; Y Kawaguchi; T Hosoya
Journal:  Kidney Int       Date:  1998-02       Impact factor: 10.612

4.  Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism.

Authors:  T Carling; P Ridefelt; P Hellman; J Rastad; G Akerström
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

5.  The distribution of two different vitamin D receptor polymorphisms (BsmI and start codon) in primary hyperparathyroidism.

Authors:  M Sosa; A Torres; N Martín; E Salido; J M Limiñana; Y Barrios; E De Miguel; P Betancor
Journal:  J Intern Med       Date:  2000-01       Impact factor: 8.989

6.  The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women.

Authors:  C Gross; T R Eccleshall; P J Malloy; M L Villa; R Marcus; D Feldman
Journal:  J Bone Miner Res       Date:  1996-12       Impact factor: 6.741

7.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

8.  Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

Authors:  N Fukuda; H Tanaka; Y Tominaga; M Fukagawa; K Kurokawa; Y Seino
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

9.  Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3.

Authors:  M B Demay; M S Kiernan; H F DeLuca; H M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

10.  Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients.

Authors:  Y Nagaba; M Heishi; H Tazawa; Y Tsukamoto; Y Kobayashi
Journal:  Am J Kidney Dis       Date:  1998-09       Impact factor: 8.860

View more
  6 in total

1.  Influence of vitamin D receptor polymorphisms on biochemical markers of mineral bone disorders in South African patients with chronic kidney disease.

Authors:  Bala Waziri; Therese Dix-Peek; Caroline Dickens; Raquel Duarte; Saraladevi Naicker
Journal:  BMC Nephrol       Date:  2018-02-07       Impact factor: 2.388

2.  Vitamin D receptor polymorphisms and bone health after kidney transplantation

Authors:  Berfu Korucu; Ajlan Tükün; Özant Helvacı; Hasan Yeter; Sevim Gönen; Galip Güz; Turgay Arınsoy
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

3.  Vitamin D receptor gene polymorphism and left ventricular hypertrophy in chronic kidney disease.

Authors:  Domenico Santoro; Giorgia Gagliostro; Angela Alibrandi; Riccardo Ientile; Guido Bellinghieri; Vincenzo Savica; Michele Buemi; Daniela Caccamo
Journal:  Nutrients       Date:  2014-03-10       Impact factor: 5.717

4.  Profile of vitamin D receptor gene polymorphism TaqI in patients with periodontitis.

Authors:  Nurlindah Hamrun; Muhammad Ruslin; Erni Marlina; Sri Oktawati; Takashi Saito; Andi Sitti Hajrah Yusuf; Keng-Liang Ou
Journal:  Biomed Rep       Date:  2022-03-01

5.  Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk.

Authors:  Morteza Bagheri; Isa Abdi Rad; Nima Hosseini Jazani; Fariba Nanbakhsh
Journal:  Int J Fertil Steril       Date:  2013-07-31

6.  Genome-wide meta-analysis identifies novel loci associated with parathyroid hormone level.

Authors:  Antonela Matana; Dubravka Brdar; Vesela Torlak; Thibaud Boutin; Marijana Popović; Ivana Gunjača; Ivana Kolčić; Vesna Boraska Perica; Ante Punda; Ozren Polašek; Maja Barbalić; Caroline Hayward; Tatijana Zemunik
Journal:  Mol Med       Date:  2018-04-11       Impact factor: 6.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.